Agenus Inc. (AGEN) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Agenus Inc.
Agenus Inc., a clinical-stage biotechnology company, discovers and develops immunotherapies for cancer and infectious diseases in the United States and internationally. It offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal…
Source: Yahoo Finance
Sector & Industry
Agenus Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Agenus Inc. at a Glance
| Company | Agenus Inc. |
| Ticker | AGEN |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $8.24 |
| Market cap | $370.88M |
| P/E ratio (trailing) | 2.76 |
| EPS (trailing) | $2.99 |
| 52-week high | $8.85 |
| 52-week low | $2.71 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 1.40 |
| Return on equity (ROE) | — |
| Debt-to-equity | — |
| Average volume | 4.21M |
| Shares outstanding | 45.01M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 81 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Frequently Asked Questions
- What is Agenus Inc.'s current P/E ratio?
- Agenus Inc. (AGEN) has a trailing P/E ratio of 2.76 as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Agenus Inc.'s market capitalisation?
- Agenus Inc.'s market cap is $370.88M based on our latest snapshot. See how it ranks by market cap →
- What is AGEN's 52-week range?
- Over the past 52 weeks, AGEN has traded between $2.71 and $8.85. What does the 52-week range mean? →
- How volatile is Agenus Inc. compared to the market?
- Agenus Inc. has a beta of 1.40, meaning it has historically moved more than the broader market. What does beta measure? →
- Does Agenus Inc. pay a dividend?
- Agenus Inc. does not currently pay a dividend according to our latest data.
- What exchange is AGEN listed on?
- AGEN is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Agenus Inc. in?
- Agenus Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Working out potential returns or position sizes? Our payout and odds calculators handle the maths.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →